Nicolas Musi

发表

Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes.

Olle Ljunqvist, D. Moller, L. Goodyear, 2002, Diabetes.

Reduced Skeletal Muscle Inhibitor of κBβ Content Is Associated With Insulin Resistance in Subjects With Type 2 Diabetes: Reversal by Exercise Training

Ralph A. DeFronzo, Rachele Berria, Lawrence J. Mandarino, 2006 .

Pioglitazone for diabetes prevention in impaired glucose tolerance.

Devjit Tripathy, G. Bray, S. Mudaliar, 2011, The New England journal of medicine.

Energy Expenditure Evaluation in Humans and Non-Human Primates by SenseWear Armband. Validation of Energy Expenditure Evaluation by SenseWear Armband by Direct Comparison with Indirect Calorimetry

Livio Luzi, A. Comuzzie, F. Folli, 2013, PloS one.

Prevention of Diabetes With Pioglitazone in ACT NOW

Robert R. Henry, Amalia Gastaldelli, George A. Bray, 2013, Diabetes.

Actos Now for the prevention of diabetes (ACT NOW) study

Devjit Tripathy, G. Bray, S. Mudaliar, 2009, BMC endocrine disorders.

Pioglitazone Slows Progression of Atherosclerosis in Prediabetes Independent of Changes in Cardiovascular Risk Factors

Wendy J Mack, Aramesh Saremi, Devjit Tripathy, 2013, Arteriosclerosis, thrombosis, and vascular biology.

Diabetes and Cardiovascular Disease in Older Adults: Current Status and Future Directions

Kevin P. High, Elbert S. Huang, J. Halter, 2014, Diabetes.

Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOW.

Devjit Tripathy, G. Bray, S. Mudaliar, 2016, The Journal of clinical endocrinology and metabolism.

APPL1 Potentiates Insulin Sensitivity by Facilitating the Binding of IRS1/2 to the Insulin Receptor

Feng Dong, Steven N. Austad, Feng Liu, 2014, Cell reports.

Insulin resistance and improvements in signal transduction

L. Goodyear, N. Musi, Nicolas Musi, 2006, Endocrine.